The human body may use the cannabinoid pathway to make placebos effective, according to a Wired report based on a study from Nature Medicine. According to the report, placebo-activated opioid ...
WASHINGTON, DC / ACCESS Newswire / March 24, 2026 / A new federal initiative allowing up to $500 annually in hemp-derived cannabinoid products for Medicare beneficiaries is raising urgent questions ...
Duane Boise CEO stated, "As cannabinoid policy shifts from retail access toward physician directed treatment and insurance participation, companies with IND programs, orphan-drug positioning, and ...
MD, Inc. (NYSE American: YCBD), a leader in science-driven cannabinoid products, today announced the launch of its clinical healthcare channel, positioning the Company to support physicians, health ...
"As CMS Prepares to Launch the First Federal Cannabinoid Reimbursement Program, Industry Leaders Warn of a Dangerous Shift ...
The study highlights brain changes from tobacco use and calls for more research on cannabis, as its effects on brain ...
VANCOUVER, British Columbia, July 14, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (HYTNF) (“HYTN” or the “Company”), a leader in pharmaceutical-grade cannabis manufacturing, is pleased to announce ...
Cannabigerol (CBG) is not just a compound; it’s a spectral presence. A paracannabinoid. It shows up early in the life of the cannabis plant, before the more famous molecules take shape. It’s there at ...
"Companies like ours followed that pathway for years under Schedule I restrictions, completed IND submissions, secured orphan drug designation, and developed standardized dose-form cannabinoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results